Promising MS drug increases neuroprotection
Tuesday, December 6, 2011 - 12:01
in Health & Medicine
Laquinimod is an orally available synthetic compound that has been successfully evaluated in phase II/III clinical studies for the treatment of relapsing-remitting multiple sclerosis (RRMS). The...